10th October, 2019

Nifty 50 Sensex Open 11,152.95 Open 37,628.05 High 11,321.60 High 38,209.84 Low 11,090.15 Low 37,415.83 Close 11,319.60 Close 38,177.95 % Chg. +1.74% % Chg. +1.72%

STOCK INDICES Closing % Chg. BSE SENSEX 38,177.95 +1.72% Domestic Corporate – BSE MIDCAP 13,869.35 +1.38% NIFTY 50 11,319.60 +1.74% Indiabulls Housing Finance: Reserve Bank on Wednesday rejected the NIFTY MIDCAP 50 4,308.15 +2.04% proposed merger of Indiabulls Housing Finance with troubled private NIFTY BANK 28,795.20 +3.70% sector lender Lakshmi Vilas Bank. Nifty 50 Top Gainers LTP % Chg. Prev. Close INDUSINDBK 1,309.50 5.52% 1,241.05 : Citing commercial losses, the financially troubled Essel INFRATEL 259.2 5.34% 246.05 Group of on announced a withdrawal of its daily BHARTIARTL 359.4 5.23% 341.55 newspaper, DNA. SBIN 261.8 5.10% 249.1 ULTRACEMCO 4,061.00 4.92% 3,870.40 : Reliance Jio said it will charge 6 paise per minute for Nifty 50 Top Losers LTP % Chg. Prev. Close voice calls made by its users to mobile phones networks of rivals like YESBANK 43.3 -5.15% 45.65 HEROMOTOCO 2,599.00 -2.80% 2,674.00 Airtel and Vodafone-Idea. ZEEL 245.55 -2.37% 251.5 TITAN 1,230.40 -2.27% 1,259.00 : Infosys said it has entered into a strategic partnership with HCLTECH 1,051.05 -2.17% 1,074.40 Eishtec under which 1,400 employees of the Irish firm will be transferred Securities Ban in Trade to Infosys BPM.

NHPC: NHPC said it has completed the formalities for taking over 500 MW Teesta VI hydro power project, which it has bagged under corporate insolvency resolution process.

Bharti Airtel: Telecom operator said it has raised USD 750 million from investors based in Asia, Europe and the US through a hybrid financial instrument.

Torrent Pharma: Torrent Pharmaceuticals on Wednesday said it has received a warning letter from the US health regulator for its Indrad facility in . This action by the United States Food and Drug Administration (USFDA) follows earlier intimation received from the regulator in August 2019, wherein the agency had classified its inspection as "Official Action Indicated"

Zydus Cadila: The drug maker said it has received final approval from the US heath regulator to market generic cholesterol lowering Colesevelam Hydrochloride tablets.

Comment – Snapping their six-day losing streak, the benchmark indices staged a smart comeback on Wednesday to end nearly 2% higher, led by heavy buying in bank stocks.

Wallfort Research Page 1 of 2

10th October, 2019

Wallfort Research is also available on Bloomberg

Disclaimer: This document has been prepared by the Research Division of Wallfort Ltd. , (WFSL) and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of WFSL. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, WFSL has not independently verified the accuracy or completeness of the same. Neither WFSL nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient's particular circumstances and, in case of doubt, advice should be sought from an independent expert/advisor. Either WFSL or its affiliates or its directors or its employees or its representatives or its clients or their relatives may have position(s), make market, act as principal or engage in transactions of securities of companies referred to in this report and they may have used the research material prior to publication. We may from time to time solicit or perform investment banking or other services for any company mentioned in this document.

Wallfort Research Page 2 of 2